Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
CHANGE IN RATINGS
upgraded at Dahlman Rose from Hold to Buy. $22 price target. Company is seeing higher volumes and is keeping a tight lid on costs.
upgraded at Oppenheimer from Perform to Outperform, Oppenheimer said. $74 price target. Company continues to grow its business in the emerging markets.
upgraded at Kaufman from Hold to Buy, Kaufman Bros. said. $165 price target. Stock is down 25% from January highs and the company will likely emerge as a clear winner in the solar industry.
downgraded at BMO from Outperform to Market Perform, BMO Capital said. Valuation call, based on a $7 price target.
rated new Buy at Goldman. $6.25 price target. Company is operating in a favorable price environment and is keeping a lid on its costs.
( GRM) downgraded at Goldman from Buy to Neutral, Goldman Sachs said. $24 price target. Valuation call, as the stock is up 38% over the past two weeks.
downgraded at Morgan Stanley to Equal-weight, Morgan Stanley said. $18 price target. Valuation call, as the stock is up 50% over the past three months.
downgraded at Citi to Sell from Hold. Solid 1Q11 upside and new $1 billion buyback program, Citigroup noted. Price target increased to $54 from $52.
upgraded at BMO from Market Perform to Outperform, BMO Capital said. $60 price target. Company is seeing better demand from key end markets.
upgraded at Citi to Buy from Hold on strong 1Q11 results, improving fundamentals, Citigroup said. Price target jumps to $122 from $90.
downgraded at Citi to Hold from Buy. Growth/margin trade-off yielding no EPS growth, Citigroup said. Price target cut to $36 from $55.
downgraded at Brean from Buy to Hold, Brean Murray said. Company is facing new sales and margin headwinds.
rated new Hold at ThinkEquity. $8 price target. Company faces a long transition from its legacy Symbian products.
downgraded at FBR from Outperform to Market Perform, FBR Capital Markets said. Valuation call
rated new Buy at ThinkEquity. $5 price target. Company is the best large-cap chip play on smartphones and tablets.
numbers boosted at Morgan Stanley. Shares of ROP now seen reaching $88, according to Morgan Stanley. Estimates also upped, as higher sales is driving margin expansion. Equal-weight rating.
downgraded at Oppenheimer from Outperform to Perform, Oppenheimer said. Valuation call.
rated new Outperform at Morgan Keegan. $45 price target. Company is a market leader and is expanding its commercial footprint.
downgraded at Jefferies from Buy to Hold, Jefferies said. Store manager survey showed worsening near-term trends. $25 price target.
downgraded at Goldman from Buy to Neutral. $56 price target. Estimates also cut, to match the company's new guidance.
End of report.
This article was written by a staff member of TheStreet.